XML 35 R20.htm IDEA: XBRL DOCUMENT
v3.23.2

Accrued Liabilities (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2023
Accrued Liabilities, Current [Abstract] |
Schedule of Accrued Liabilities | Accrued liabilities as of June 30, 2023 and December 31, 2022 consisted of the following (in thousands):
|  | June 30, 2023 |  |  | December 31, 2022 |
Contract research organization costs |  | $ | 58,050 |  |  | $ | 53,119 |
Other clinical study related costs |  |  | 3,605 |  |  |  | 6,582 |
Manufacturing and drug supply |  |  | 3,556 |  |  |  | 11,262 |
Compensation and benefits |  |  | 5,453 |  |  |  | 14,864 |
Professional fees |  |  | 9,494 |  |  |  | 4,867 |
Other |  |  | 1,603 |  |  |  | 767 |
Total accrued liabilities |  | $ | 81,761 |  |  | $ | 91,461 |

X
- References No definition available. + Details
Name: | us-gaap_AccruedLiabilitiesCurrentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accrued liabilities. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration